In the CFA and MIA models of arthritis of the knee, the TRPA1 antagonists HC-030031 and AP-18 relieved behavioral sensitization via elevation of mechanical withdrawal thresholds and normalization of weight-bearing between the arthritic and healthy hind-legs [91,92]. The gene discussed is TRPA1; the disease is arthritic joint disease.